File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1081/CNV-100103131
- Scopus: eid_2-s2.0-0035019750
- PMID: 11405176
- WOS: WOS:000169919100005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells
Title | Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells |
---|---|
Authors | |
Keywords | Chemotherapy Cisplatin Gene Transfer Mitomycin C P53 |
Issue Date | 2001 |
Publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/07357907.asp |
Citation | Cancer Investigation, 2001, v. 19 n. 4, p. 360-368 How to Cite? |
Abstract | This study investigated the enhanced antitumor activity of Ad5-p53 in combination with mitomycin C (MMC) or cisplatin (DDP) in cervical cancer cell lines SiHa and C-33A. MMC and DDP inhibited the growth of SiHa and C-33A cells in a dose-dependent manner, and the combination of MMC or DDP with Ad5-p53 showed a stronger growth inhibition than those treated with either Ad5-p53, MMC, or DDP alone. As evidenced by the formation of the ∼200 bp DNA ladder and the appearance of sub-G1 peak both MMC and DDP induced apoptosis in cervical cancer cells. Western blot analysis of p53 showed that MMC/DDP did not induce the increase of p53 protein in SiHa cells nor the increase of the cellular and nuclear p53 protein in Ad5-p53 transfected Saos-2 cells. Taken together, these results suggested that the combination of Ad5-p53 and MMC/DDP may serve as an effective therapeutic regime for human cervical cancer treatment. |
Persistent Identifier | http://hdl.handle.net/10722/87448 |
ISSN | 2023 Impact Factor: 1.8 2023 SCImago Journal Rankings: 0.604 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huang, TG | en_HK |
dc.contributor.author | Ip, SM | en_HK |
dc.contributor.author | Yeung, WSB | en_HK |
dc.contributor.author | Ngan, HYS | en_HK |
dc.date.accessioned | 2010-09-06T09:29:47Z | - |
dc.date.available | 2010-09-06T09:29:47Z | - |
dc.date.issued | 2001 | en_HK |
dc.identifier.citation | Cancer Investigation, 2001, v. 19 n. 4, p. 360-368 | en_HK |
dc.identifier.issn | 0735-7907 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/87448 | - |
dc.description.abstract | This study investigated the enhanced antitumor activity of Ad5-p53 in combination with mitomycin C (MMC) or cisplatin (DDP) in cervical cancer cell lines SiHa and C-33A. MMC and DDP inhibited the growth of SiHa and C-33A cells in a dose-dependent manner, and the combination of MMC or DDP with Ad5-p53 showed a stronger growth inhibition than those treated with either Ad5-p53, MMC, or DDP alone. As evidenced by the formation of the ∼200 bp DNA ladder and the appearance of sub-G1 peak both MMC and DDP induced apoptosis in cervical cancer cells. Western blot analysis of p53 showed that MMC/DDP did not induce the increase of p53 protein in SiHa cells nor the increase of the cellular and nuclear p53 protein in Ad5-p53 transfected Saos-2 cells. Taken together, these results suggested that the combination of Ad5-p53 and MMC/DDP may serve as an effective therapeutic regime for human cervical cancer treatment. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/07357907.asp | en_HK |
dc.relation.ispartof | Cancer Investigation | en_HK |
dc.rights | Cancer Investigation. Copyright © Informa Healthcare. | en_HK |
dc.subject | Chemotherapy | en_HK |
dc.subject | Cisplatin | en_HK |
dc.subject | Gene Transfer | en_HK |
dc.subject | Mitomycin C | en_HK |
dc.subject | P53 | en_HK |
dc.title | Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0735-7907&volume=19&issue=4&spage=360&epage=368&date=2001&atitle=Mitomycin+C+and+cisplatin+enhanced+the+antitumor+activity+of+p53-expressing+adenovirus+in+cervical+cancer+cells | en_HK |
dc.identifier.email | Yeung, WSB:wsbyeung@hkucc.hku.hk | en_HK |
dc.identifier.email | Ngan, HYS:hysngan@hkucc.hku.hk | en_HK |
dc.identifier.authority | Yeung, WSB=rp00331 | en_HK |
dc.identifier.authority | Ngan, HYS=rp00346 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1081/CNV-100103131 | en_HK |
dc.identifier.pmid | 11405176 | - |
dc.identifier.scopus | eid_2-s2.0-0035019750 | en_HK |
dc.identifier.hkuros | 65263 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0035019750&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 19 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 360 | en_HK |
dc.identifier.epage | 368 | en_HK |
dc.identifier.isi | WOS:000169919100005 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Huang, TG=7404962005 | en_HK |
dc.identifier.scopusauthorid | Ip, SM=55041321600 | en_HK |
dc.identifier.scopusauthorid | Yeung, WSB=7102370745 | en_HK |
dc.identifier.scopusauthorid | Ngan, HYS=34571944100 | en_HK |
dc.identifier.issnl | 0735-7907 | - |